Below are our Buy calls for Wednesday, 28 October, as follows:
Intellia Therapeutics Inc. (NASDAQ:NTLA) was started with a Buy rating and a 40 price target at Truist Securities, which noted that the 1st in-human systemically delivered CRISPR offers investors a compelling Northside story.
iRobot Corp. (NASDAQ:IRBT) said Q-3 sales soared as consumers bought products for their homes. Shares closed Tuesday at 85.18 and have a consensus price target of 82.00.
Have a healthy day, Keep the Faith!
Latest posts by Paul Ebeling (see all)
- Sitting on a Cash Pile 10.0? Lots of People are Going to Fly Again Soon - January 21, 2021
- Wall Street’s Key Stock Analysts Research Report, All Buys - January 21, 2021
- Thursday’s World Stock Markets: Asia-Pacific - January 21, 2021